Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429075

Director bought 3,680 shares at $27.08 ($99,636)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silva Paul M Director 2026-10-22 Purchase +3,680 $27.08 $99,636 3,680 I
Open-market purchases · 3,680 sh · avg $27.08 · $99,636
Loading xslF345X06/ownership.xml…